pim-3 kinase inhibitors (Kanazawa/KUTLO-NITT)

N/A

Report date: 2025/03/20 09:57:23
NME

Base Information

Drug Namepim-3 kinase inhibitors (Kanazawa/KUTLO-NITT)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase pim-3 inhibitors
TargetsSerine/threonine-protein kinase pim-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKanazawa University
China Registration ClassN/A

Develop Information

Active CompaniesKanazawa University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A